Siemens, Other Top Dx Firms Wax Molecular At AACC Lab Conference
This article was originally published in The Gray Sheet
Executive Summary
Siemens bought its way to the top of the in vitro diagnostics market during the past two years and is now aiming to make gains in one of the fastest growing segments of that sector - molecular diagnostics
You may also be interested in...
Abbott Diagnostics Unit Teams Up With Big Pharma On Companion Test
Abbott's molecular diagnostics business announced March 7 a collaboration with Genentech, Roche and OSI Pharmaceuticals to develop a gene test that helps select patients more likely to respond to the lung cancer drug Tarceva
Ibis Prepares Next-Gen Microorganism Detector For Diagnostic Space
Five years ago the U.S. Department of Defense commissioned California-based Isis Pharmaceuticals to develop a new technology to more easily detect bioterrorism agents. Now, $55.6 million in government grants later, the company is readying the Ibis T5000 Biosensor System to make its way into the in vitro diagnostics space
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.